These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28089995)

  • 1. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.
    Bharathan SP; Manian KV; Aalam SM; Palani D; Deshpande PA; Pratheesh MD; Srivastava A; Velayudhan SR
    Biol Open; 2017 Jan; 6(1):100-108. PubMed ID: 28089995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts.
    Polak U; Hirsch C; Ku S; Gottesfeld J; Dent SY; Napierala M
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22370855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
    Tesarova L; Simara P; Stejskal S; Koutna I
    PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer.
    Miller JD; Schlaeger TM
    Methods Mol Biol; 2011; 767():55-65. PubMed ID: 21822867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of bone marrow derived mesenchymal stromal cells to human induced pluripotent stem cells from pediatric patients with hematological diseases using a commercial mRNA kit.
    Sfougataki I; Grafakos I; Varela I; Mitrakos A; Karagiannidou A; Tzannoudaki M; Poulou M; Mertzanian A; Roubelakis G M; Stefanaki K; Traeger-Synodinos J; Kanavakis E; Kitra V; Tzetis M; Goussetis E
    Blood Cells Mol Dis; 2019 May; 76():32-39. PubMed ID: 30709626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells.
    Manian KV; Aalam SM; Bharathan SP; Srivastava A; Velayudhan SR
    Cell Reprogram; 2015 Dec; 17(6):427-40. PubMed ID: 26562626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-specificity Tyrosine Phosphorylation-regulated Kinase Inhibitor ID-8 Promotes Human Somatic Cell Reprogramming by Activating PDK4 Expression.
    Xu J; Fang S; Wang N; Li B; Huang Y; Fan Q; Shi J; Liu H; Shao Z
    Stem Cell Rev Rep; 2022 Aug; 18(6):2074-2087. PubMed ID: 35080746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
    Kamada M; Mitsui Y; Matsuo T; Takahashi T
    Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem cells differentiated from iPS cells spontaneously regain pluripotency.
    Choi HW; Kim JS; Choi S; Hong YJ; Kim MJ; Seo HG; Do JT
    Stem Cells; 2014 Oct; 32(10):2596-604. PubMed ID: 24898298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
    Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
    Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS-based cell depletion facilitates the selective isolation of mouse induced pluripotent stem cells.
    Warlich E; Schambach A; Lock D; Wedekind D; Glage S; Eckardt D; Bosio A; Knöbel S
    PLoS One; 2014; 9(7):e102171. PubMed ID: 25029550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.